Geopolitics Alpha

Live · last trade · ETF proxies, Alpaca IEX

Here’s what’s been proven to help GLP-1 users from losing too much muscle from the drug

Published . Updated .

Key takeaways

  • People taking Zepbound who engage in consistent resistance training can still get stronger even if they lose some of their muscle, according to a new study.
  • Exposed: XLV, XBI, LLY, JNJ, PFE
  • Market reaction: price tracking starts with the next trading session.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest and never sell or share it. See our privacy policy.

GEOPOLITICS ALPHAHere’s what’s been proven to helpGLP-1 users from losing too muchmuscle from the drugGEOPOLITICS ALPHA

People taking Zepbound who engage in consistent resistance training can still get stronger even if they lose some of their muscle, according to a new study.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “drug” (pharma and health) in this story.

  • XBI SPDR S&P Biotech ETF

    SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “drug” (pharma and health) in this story.

  • LLY Eli Lilly and+25.1% 30d

    Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story.

  • JNJ Johnson & Johnson+12.1% 30d

    Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story.

  • PFE Pfizer+5.2% 30d

    Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story.

  • MRK Merck+3.5% 30d

    Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “drug” (pharma and health) in this story.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
XLVPrices arriving within minutes———after closeafter closeafter closeafter close
XBIPrices arriving within minutes———after closeafter closeafter closeafter close
LLYPrices arriving within minutes———after closeafter closeafter closeafter close
JNJPrices arriving within minutes———after closeafter closeafter closeafter close
PFEPrices arriving within minutes———after closeafter closeafter closeafter close
MRKPrices arriving within minutes———after closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

People taking Zepbound who engage in consistent resistance training can still get stronger even if they lose some of their muscle, according to a new study.

Source: MarketWatch

Trades by members of Congress and officials in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

This story

12 out of 100

“Here’s what’s been proven to help GLP-1 users from losing too much muscle from the drug” scores 12 out of 100. The score uses 1 source.